Clinical trial

Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative…

NCT00259545 · Heidelberg University, Other · Completed

Key facts

NCT number NCT00259545
Title Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis
Official title Prospektive, Randomisierte Doppelblinde Studie Zur Wirksamkeit Von Intestinal Retardiert Freigesetztem Phosphatidylcholine Bei therapierefraktärer Colitis Ulcerosa Mit Chronisch Aktivem Verlauf Unter Corticosteroiden
Lead sponsor Heidelberg University, Other
Collaborators Professor Wolfgang Stremmel Dietmar Hopp Stiftung
Status Completed
Phase Phase 2
Study type Interventional
Conditions Ulcerative Colitis, Phosphatidylcholine
Intervention type Drug
Interventions Retarded Release Phosphatidylcholine (rPC)
Enrollment 60
Start date Feb 1, 2003
Completion Feb 1, 2006
First posted Nov 29, 2005
Last update posted Jun 5, 2008
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies